{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:45:37Z","timestamp":1785725137002,"version":"3.56.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,27]],"date-time":"2027-06-27T00:00:00Z","timestamp":1814054400000},"content-version":"am","delay-in-days":269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218692","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:49:21Z","timestamp":1782283761000},"page":"218692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting MDA-9\/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells"],"prefix":"10.1016","volume":"657","author":[{"given":"Grace J.","family":"Rilee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadid U.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanakaraju","family":"Manupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie G.","family":"Hoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-4877","authenticated-orcid":false,"given":"Manny D.","family":"Bacolod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion Q.","family":"Lopresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swadesh K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-5140","authenticated-orcid":false,"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218692_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218692_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI82066","article-title":"Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma","volume":"126","author":"Hedberg","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218692_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oraloncology.2018.08.001","article-title":"Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma","volume":"85","author":"Lee","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2026.218692_bib4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218692_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hed.23684","article-title":"Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"37","author":"Tanvetyanon","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2026.218692_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.acr.2021.05.002","article-title":"Head and neck cancer: current challenges and future perspectives","volume":"152","author":"Bhat","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218692_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","article-title":"Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis","volume":"15","author":"Pulte","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218692_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcp.22767","article-title":"Emerging strategies for the early detection and prevention of head and neck squamous cell cancer","volume":"227","author":"Dasgupta","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218692_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","article-title":"Dormancy and cancer stem cells: an enigma for cancer therapeutic targeting","volume":"141","author":"Talukdar","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.acr.2016.04.003","article-title":"Evolving strategies for therapeutically targeting cancer stem cells","volume":"131","author":"Talukdar","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010053","article-title":"MDA-9\/Syntenin (SDCBP) is a critical regulator of chemoresistance, survival and stemness in prostate cancer stem cells","volume":"12","author":"Talukdar","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218692_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218692_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrc1694","article-title":"Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression","volume":"5","author":"Brabletz","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218692_bib15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/ijc.25927","article-title":"Head neck squamous cell carcinoma c-Met(+) cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis","volume":"129","author":"Sun","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218692_bib16","article-title":"Cisplatin-based chemotherapy options for recurrent and\/or metastatic squamous cell cancer of the head and neck","volume":"2013","author":"Pendleton","year":"2013","journal-title":"Clin. Med. Insights Ther."},{"key":"10.1016\/j.canlet.2026.218692_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.02.003","article-title":"Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218692_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(97)00562-3","article-title":"Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene","volume":"207","author":"Lin","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2026.218692_bib19","first-page":"317","article-title":"Characterization of a novel melanoma differentiation associated gene, mda-9, that is down-regulated during terminal cell differentiation","volume":"4","author":"Lin","year":"1996","journal-title":"Mol. Cell. Differ."},{"key":"10.1016\/j.canlet.2026.218692_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pharmthera.2004.08.004","article-title":"mda-9\/syntenin: recent insights into a novel cell signaling and metastasis-associated gene","volume":"104","author":"Sarkar","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218692_bib21","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1158\/0008-5472.CAN-05-1614","article-title":"mda-9\/Syntenin: a positive regulator of melanoma metastasis","volume":"65","author":"Boukerche","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib22","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-07-6210","article-title":"mda-9\/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis","volume":"68","author":"Sarkar","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3911","article-title":"MDA-9\/syntenin: a positive gatekeeper of melanoma metastasis","volume":"17","author":"Das","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.canlet.2026.218692_bib24","doi-asserted-by":"crossref","first-page":"54102","DOI":"10.18632\/oncotarget.10851","article-title":"Novel function of MDA-9\/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells","volume":"7","author":"Talukdar","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218692_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/14728222.2014.959495","article-title":"Targeting tumor invasion: the roles of MDA-9\/Syntenin","volume":"19","author":"Kegelman","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2026.218692_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104695","article-title":"MDA-9\/Syntenin (SDCBP): novel gene and therapeutic target for cancer metastasis","volume":"155","author":"Das","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218692_bib27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10555-020-09886-7","article-title":"MDA-9\/Syntenin\/SDCBP: new insights into a unique multifunctional scaffold protein","volume":"39","author":"Pradhan","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218692_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.1616100114","article-title":"Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9\/Syntenin","volume":"114","author":"Kegelman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218692_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2025.2472042","article-title":"MDA-9\/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding","volume":"29","author":"Das","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2026.218692_bib30","doi-asserted-by":"crossref","first-page":"82634","DOI":"10.18632\/oncotarget.13020","article-title":"Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218692_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.18632\/oncoscience.99","article-title":"MDA-9\/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma","volume":"1","author":"Oyesanya","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.canlet.2026.218692_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194952","article-title":"SDCBP modulates stemness and chemoresistance in head and neck squamous cell carcinoma through src activation","volume":"13","author":"Mir","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218692_bib33","article-title":"The multifunctional protein Syntenin-1: regulator of exosome biogenesis, cellular function, and tumor progression","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218692_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan-syntenin-ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218692_bib35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218692_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.acr.2019.03.011","article-title":"MDA-9\/Syntenin: an emerging global molecular target regulating cancer invasion and metastasis","volume":"144","author":"Das","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113601","article-title":"Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread","volume":"223","author":"Garcia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218692_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103180118","article-title":"Pharmacological inhibition of MDA-9\/Syntenin blocks breast cancer metastasis through suppression of IL-1beta","volume":"118","author":"Pradhan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218692_bib39","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1535-7163.MCT-18-1019","article-title":"Suppression of prostate cancer pathogenesis using an MDA-9\/Syntenin (SDCBP) PDZ1 small-molecule inhibitor","volume":"18","author":"Das","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218692_bib40","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/acs.jmedchem.2c01569","article-title":"Discovery of a PDZ domain inhibitor targeting the syndecan\/syntenin protein-protein interaction: a semi-automated \"Hit Identification-to-Optimization\" approach","volume":"66","author":"Hoffer","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218692_bib41","article-title":"Inhibitors against two PDZ domains of MDA-9 suppressed migration of breast cancer cells","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218692_bib42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1158\/1535-7163.MCT-22-0653","article-title":"Dual targeting of the PDZ1 and PDZ2 domains of MDA-9\/Syntenin inhibits melanoma metastasis","volume":"22","author":"Pradhan","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218692_bib43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/biom14101287","article-title":"Design and synthesis of small molecule probes of MDA-9\/Syntenin","volume":"14","author":"Sankaranarayanan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218692_bib44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0969-2126(03)00125-4","article-title":"Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm","volume":"11","author":"Kang","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.canlet.2026.218692_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174171","article-title":"Syntenin: PDZ protein regulating signaling pathways and cellular functions","volume":"20","author":"Shimada","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218692_bib46","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1038\/s41388-019-0920-5","article-title":"Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9\/Syntenin","volume":"38","author":"Bhoopathi","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218692_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101287","article-title":"Design and synthesis of small molecule probes of MDA-9\/Syntenin","volume":"14","author":"Sankaranarayanan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218692_bib48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218692_bib49","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218692_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.678966","article-title":"EGFR and PI3K pathway activities might guide drug repurposing in HPV-negative head and neck cancers","volume":"11","author":"Mock","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218692_bib51","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00405-020-06214-1","article-title":"A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma","volume":"278","author":"Metzger","year":"2021","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.canlet.2026.218692_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2020.12.007","article-title":"Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma","volume":"39","author":"Huang","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218692_bib53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jcp.29044","article-title":"Cancer stem cells: a review from origin to therapeutic implications","volume":"235","author":"Atashzar","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218692_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1593\/neo.131744","article-title":"Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer","volume":"16","author":"Nor","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2026.218692_bib55","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/onc.2010.65","article-title":"Src kinase activation is mandatory for MDA-9\/syntenin-mediated activation of nuclear factor-kappaB","volume":"29","author":"Boukerche","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218692_bib56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.csbj.2019.01.002","article-title":"A PDZ protein MDA-9\/Syntenin: as a target for cancer therapy","volume":"17","author":"Yu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.canlet.2026.218692_bib57","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-021-24137-1","article-title":"Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218692_bib58","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7150\/thno.22182","article-title":"Cancer-associated fibroblast-derived IL-6 promotes head and neck cancer progression via the Osteopontin-NF-kappa B signaling pathway","volume":"8","author":"Qin","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218692_bib59","article-title":"Co-targeting BMI1 and MYC to eliminate cancer stem cells in squamous cell carcinoma","volume":"6","author":"Qin","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218692_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108164","article-title":"MDA-9\/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis","volume":"227","author":"Maji","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218692_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114778","article-title":"New advances into cisplatin resistance in head and neck squamous carcinoma: mechanisms and therapeutic aspects","volume":"163","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218692_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041034","article-title":"Biological role and aberrant overexpression of Syntenin-1 in cancer: potential role as a biomarker and therapeutic target","volume":"11","author":"Pintor-Romero","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218692_bib63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.18632\/oncotarget.6299","article-title":"MDA-9\/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion\/metastasis in lung adenocarcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218692_bib64","doi-asserted-by":"crossref","first-page":"80175","DOI":"10.18632\/oncotarget.13373","article-title":"MDA-9\/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor beta1 to enhance epithelial-mesenchymal transition in breast cancer","volume":"7","author":"Menezes","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218692_bib65","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-12-1681","article-title":"MDA-9\/syntenin and IGFBP-2 promote angiogenesis in human melanoma","volume":"73","author":"Das","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib66","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1158\/0008-5472.CAN-17-2992","article-title":"The MDA-9\/Syntenin\/IGF1R\/STAT3 axis directs prostate cancer invasion","volume":"78","author":"Das","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41419-022-04594-2","article-title":"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218692_bib68","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1038\/sj.onc.1205514","article-title":"Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines","volume":"21","author":"Koo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218692_bib69","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1073\/pnas.1721650115","article-title":"MDA-9\/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells","volume":"115","author":"Talukdar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218692_bib70","article-title":"PRKAR1A and SDCBP serve as potential predictors of heart failure following acute myocardial infarction","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218692_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v14102202","article-title":"A syntenin inhibitor blocks endosomal entry of SARS-CoV-2 and a panel of RNA viruses","volume":"14","author":"Lindqvist","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.canlet.2026.218692_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/v16081214","article-title":"Interaction between SARS-CoV PBM and cellular PDZ domains leading to virus virulence","volume":"16","author":"Honrubia","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.canlet.2026.218692_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.stem.2025.01.011","article-title":"Sustained NF-kappaB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor initiation","volume":"32","author":"England","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218692_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-025-00994-3","article-title":"Innate immunity and the NF-kappaB pathway control prostate stem cell plasticity, reprogramming and tumor initiation","author":"Jiang","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218692_bib75","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/bcr2886","article-title":"NF-kappaB, stem cells and breast cancer: the links get stronger","volume":"13","author":"Shostak","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2026.218692_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218692_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2022.08.013","article-title":"Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer","volume":"175","author":"de Roest","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218692_bib78","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ymthe.2021.03.024","article-title":"FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program","volume":"29","author":"Zhang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2026.218692_bib79","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1021\/bi052225y","article-title":"The binding of the PDZ tandem of syntenin to target proteins","volume":"45","author":"Grembecka","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2026.218692_bib80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.canlet.2026.218692_bib81","series-title":"Release 2025-3","author":"Schr\u00f6dinger","year":"2025"},{"key":"10.1016\/j.canlet.2026.218692_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.canlet.2026.218692_bib83","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:22:11Z","timestamp":1785723731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":83,"alternative-id":["S0304383526004568"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218692","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MDA-9\/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218692"}}